Trial enrolls over 250 contacts in Congo testing antiviral pill to prevent Ebola
More than 250 people have enrolled in a trial in eastern Congo testing an antiviral pill to prevent Bundibugyo Ebola after exposure. The study gives the drug as post-exposure prophylaxis to people traced within five days of contact and monitors them daily for 21 days to watch for symptoms.
Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.